AI support for breast cancer patients on CDK4/6 inhibitors
Part of Cancer, Skin clinical trials.
This trial tests whether an AI-powered management program can improve mental health and daily habits for people with HR+/HER2- breast cancer who are taking CDK4/6 inhibitor pills at home. It is designed to help you feel supported and stay on track with your rehabilitation plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older, regardless of menopause status.
- You have HR+/HER2- breast cancer.
- You are currently taking or about to start a CDK4/6 inhibitor medicine.
- You are able to perform daily activities with little or no help (ECOG score 0-2).
- You do not have a serious mental health condition like bipolar disorder or schizophrenia.
- You can understand and take part in mental health exercises and use a smartphone or computer for online tasks.
- You are already following a rehabilitation plan that includes exercise and physical therapy.
- You are not pregnant or breastfeeding, and if you could become pregnant, you have a negative pregnancy test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way of monitoring patients with advanced breast cancer who are already taking hormone therapy and a CDK4/6 inhibitor. The goal is to see if remote monitoring can improve care and quality of life.
This trial tests whether an artificial intelligence (AI) tool can help doctors decide if it is safe and effective to give you a second course of a CDK4/6 inhibitor drug (like palbociclib, ribociclib, or abemaciclib) plus hormone therapy for advanced (unresectable or metastatic) HR+/HER2- breast cancer. The goal is to only treat people whose cancer is likely to respond based on a special AI analysis of their tumor tissue.
This trial tests a mobile app that uses artificial intelligence to help women with early-stage breast cancer manage symptoms during their first chemotherapy. The app is in Arabic and is designed to make it easier to report how you're feeling and get support.
This study tests an AI-powered app that helps breast cancer survivors manage symptoms like fatigue, pain, and sleep problems after treatment. It may help you feel better by giving personalized tips to cope with these symptoms.
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
This pilot study tests a smartphone app designed to help reduce symptoms of depression and anxiety in women who have had early-stage breast cancer. The app is meant to provide practical support and coping tools to help you feel better.
Hear when a new Depression Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.